Literature DB >> 9465863

Pulmonary nodules in liver transplant recipients.

D L Paterson1, N Singh, T Gayowski, I R Marino.   

Abstract

Pulmonary nodules present a diagnostic dilemma in liver transplant recipients because of the broad differential diagnosis involved. Eleven of 155 (7.1%) liver transplant recipients at the Veterans Affairs Medical Center, Pittsburgh, developed pulmonary nodules. The underlying etiology included aspergillosis (3 cases), cryptococcosis (2), metastatic hepatocellular carcinoma (1), posttransplant lymphoproliferative disorder (1), Staphylococcus aureus (1), squamous cell carcinoma (1), adenocarcinoma of unknown primary site (1), and undifferentiated carcinoma (1). A review of the literature revealed 22 other liver transplant recipients with pulmonary nodules. There appears to be a definite relationship between time since transplantation and etiology of the nodule. Aspergillosis and bacterial infections appear early (within the first month), whereas nocardiosis, coccidiomycosis, tuberculosis, and cryptococcosis occur from 3 to 24 months posttransplantation. Metastatic hepatocellular carcinoma is a relatively common cause of pulmonary nodule and appears from 2 months to 2 years posttransplantation. Detection of skin lesions (indicating nocardiosis or cryptococcosis) and positive serologic tests may further narrow the diagnosis. However, radiographic appearances of nodules of differing etiology are relatively nonspecific, necessitating biopsy in virtually all cases.

Entities:  

Mesh:

Year:  1998        PMID: 9465863     DOI: 10.1097/00005792-199801000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  4 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Cryptococcosis in solid organ transplant recipients: current state of the science.

Authors:  Nina Singh; Francoise Dromer; John R Perfect; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

Review 3.  A titanic drug resistance threat in Cryptococcus neoformans.

Authors:  Hanna Zafar; Sophie Altamirano; Elizabeth R Ballou; Kirsten Nielsen
Journal:  Curr Opin Microbiol       Date:  2019-11-22       Impact factor: 7.934

4.  The granuloma in cryptococcal disease.

Authors:  Laura C Ristow; J Muse Davis
Journal:  PLoS Pathog       Date:  2021-03-18       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.